International Early Career Scientist
Megan Carey and Rui Costa have been awarded the International Early Career Scientist. In this pilot program, HHMI identified scientist who are, or have the potential to become, scientific leaders. The International Early Career Scientist program awards each selected scientist 650.000 USD over five years. Dr. Carey and Dr. Costa are two of the 28 recipients, chosen from 760 applicants. According to HHMI President Robert Tijan “These are the people who, 10 years from now, we expect will be the scientific leaders in their countries”.
Engineering the Mind
On Thursday, October 28, Ar celebrated its first community event at the Champalimaud Centre for the Unknown, entitled “Engineering the Mind”. Scientists, high-school and college students, doctors and Portuguese citizens of all ages gathered to get a close up view of the science done in Portugal and around the world, and to reflect on how it affects our lives and beliefs. In the spotlight, the tools humans use to modify their own brains – from drugs to electricity and light.
Champalimaud Neuroscience Symposium
Over 400 neuroscientists from around the world gathered in Lisbon for the inaugural “Champalimaud Neuroscience Symposium.” This high-level scientific meeting took place at the Champalimaud Centre for the Unknown, home of the Champalimaud Neuroscience Programme.
The symposium began on September 18th as a packed auditorium heard a lecture given by the world-renowned neuroscientist and member of the Champalimaud Foundation’s general Council, António Damásio who marked the beginning of the symposium’s scientific content which included presentations by 27 invited speakers.
Auditory Fear Learning Requires Auditory Pathways to the Amygdala
Raquel Antunes and Marta Moita published a paper in The Journal of Neuroscience, where their findings suggest that the lemniscal pathway is important for discriminative learning, whereas the nonlemniscal is important for negatively regulating fear responses.
CNP and Human Brain Project
Um cérebro humano artificial poderá ser construído dentro de dez anos, abrindo portas à compreensão do seu funcionamento e ao diagnóstico e tratamento de demências, segundo um projeto internacional hoje apresentado na Fundação Champalimaud, em Lisboa.